A case of bullous pemphigoid exacerbated by irradiation after breast conservative radiotherapy

Fumiaki Isohashi, Koji Konishi, Noriko Umegaki, Tomonori Tanei, Masahiko Koizumi, Yasuo Yoshioka

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

We present a case, considered to be a form of the Koebner phenomenon, of bullous pemphi-goid that was exacerbated mainly within the irradiated eld after breast conservative radio-therapy. In May 2009, a 60-year-old woman was diagnosed with bullous pemphigoid, which was treated with steroid therapy. The following month, she was diagnosed with breast cancer (invasive ductal carcinoma, pT1cN0M0). After breast conservative surgery in December 2009, conservative radiotherapy to the right breast was performed (50 Gy in 25 fractions). Portal skin showed no serious change (up to grade 1 skin erythema) and no bullous neogen-esis during conservative radiotherapy. However, 2 months after conservative radiotherapy, new blisters became exacerbated mainly within the irradiated eld but also in the area outside the irradiated eld. Increasing the dosage of oral steroid and minocycline resulted in relief of bullous pemphigoid, although patchy skin pigmentation remained especially in the irradiated skin.

Original languageEnglish
Article numberhyr049
Pages (from-to)811-813
Number of pages3
JournalJapanese journal of clinical oncology
Volume41
Issue number6
DOIs
Publication statusPublished - 2011 Jun

Keywords

  • Breast cancer
  • Bullous pemphigoid
  • Radiotherapy

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint Dive into the research topics of 'A case of bullous pemphigoid exacerbated by irradiation after breast conservative radiotherapy'. Together they form a unique fingerprint.

  • Cite this

    Isohashi, F., Konishi, K., Umegaki, N., Tanei, T., Koizumi, M., & Yoshioka, Y. (2011). A case of bullous pemphigoid exacerbated by irradiation after breast conservative radiotherapy. Japanese journal of clinical oncology, 41(6), 811-813. [hyr049]. https://doi.org/10.1093/jjco/hyr049